DigitalDx Ventures

It’s been a big week for DigitalDx Ventures at the Life Science Intelligence (LSI) Emerging MedTech Conference in Dana Point. On Tuesday morning (March 18) Optina Diagnostics CEO Dave Anderson addressed the conference and discussed Optina’s game-changing FDA 510(k) cleared hyper spectral camera and AI platform to enable eye specialists to more accurately diagnose and manage early, intermediate and late-stage retinal disease, including monitoring therapeutic effectiveness in at-risk patients. Tomorrow morning (March 20) at 11:25AM (PDT) NOWDiagnostics | NOWDx CEO Robert Weigle will discuss the “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes developed and manufactured by NOWDx. Last August NOWDx was granted marketing authorization by the FDA for their 'First to Know Syphilis Test.' The company’s patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or, in some cases, saliva. In addition, two of DigitalDx Ventures' Experts-in-Residence were featured at LSI. Laura Yecies CEO of Osteoboost Health, Inc. presented on stage and Debbie Lin, PhD PhD participated in a panel titled "How Can Clinical, Supplier, and Other Types of Partnerships Make Precision Medicine a Reality?" . #AI #HealthTech #HealthTechNews #ImpactInvesting #EarlyDiagnostics

CALLING ALL WOMEN ENTREPRENEURS: 🔊 The WE Empower UN SDG Challenge is live! This 🌎 global challenge for business leaders and #changemakers will bring together five awardees from around the world for UN Global Goals week to take part in tailored trainings, networking, the opportunity to pitch their businesses for a grant and much MORE. Learn more and apply TODAY! https://lnkd.in/euW87T5 Amanda Ellis Pauline Koelbl Lina Maria Useche Jaramillo Edda Aradottir Tatiana Estevez Teresa Njoroge WE Empower UN SDG Challenge #Goal5 #ShEquity #WEEmpower #ImpactInvesting #GenderLens Michele Colucci, Esq. Erin Niehaus - CFP®, CEPA

Two of DigitalDx Ventures’ portfolio company CEOs will be presenting at this week’s Life Science Intelligence (LSI) Emerging Medtech Summit in Southern California. On Tuesday morning (March 18) Optina Diagnostics CEO Dave Anderson will address the conference and discuss Optina’s game-changing FDA 510(k) cleared hyper spectral camera and AI platform to enable eye specialists to more accurately diagnose and manage early, intermediate and late-stage retinal disease, including monitoring therapeutic effectiveness in at-risk patients. On Thursday morning (March 20) NOWDiagnostics | NOWDx CEO Robert Weigle will discuss the “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes developed and manufactured by NOWDiagnostics | NOWDx. The company’s patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or, in some cases, saliva. In addition two of DigitalDx Ventures Experts in Residence Laura Yecies and Debbie Lin, PhD will also present onstage at LSI. #AI #HealthTech #HealthTechNews #ImpactInvesting #EarlyDiagnostics

DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. will be featured on a dynamic panel next week in New York titled "Activating Women in Shaping the Future of Women's Health." The panel is sponsored by Georgetown University's Hoyas in Health and Columbia University's Global Health and Wellness Network. The event is hosted by Bethany Hills Grois, JD/MPH Partner at White & Case LLP, in Manhattan. 🗓️ Tuesday, March 18, 2025 ⏰ 6:30 PM (EASTERN) Featured Speakers: ⭐ Michele Colucci, Esq. — Founder + Managing Partner DigitalDx Ventures ⭐ Jacqueline Giannelli RN, MSN, FNP-BC, NCMP — Midlife and Menopause expert ⭐ Suzanne Schmidt, MSc — Client Success Director Included Health ⭐ Amy West — Principal HITLAB Advisory Services ⭐ Hope Yates, JD, MPH — Chief Strategy Officer Women's Health Columbia University Irving Medical Center ⭐ Moderator: Delphine O'Rourke, JD #LeadersInHealth #HealthTech #ImpactInvesting #WomenInHealth #HealthTechNews

In honor of International Women's Day, all of us at DigitalDx Ventures would like to express gratitude for the extraordinary leaders on our team that make the ground-breaking work we do in health diagnostics possible. Michele Colucci, Esq., JD — Founder and Managing Partner Erin Niehaus - CFP®, CEPA, MBA  Vanessa Small PhD, MBA   Anula Jayasuriya, MD, MBA, PHD Melody Po, MBA Maureen Downey, MBA Jennifer Quigley Debbie Lin, PhD Mrunalini Parvataneni, MD Maria T. Millan, MD Alissa Hsu Lynch, MBA L. Jasmine Kim, MBA Elise Singer MD MBA, MD, MBA Hoda Asmar, MD, MBA, Tracy George, MD Jean Machart, MBA Molly Martell Renee Ryan, MBA Valerie Kozak Rumi Yokota, FPN, MBA Amit Goldman Golman, MBA Anita Samarth Laura Mezey, JD Laura Yecies MBA Carolyn Miller McCusker Stefanie Lingle Beasley #InternationalWomensDay #WomeninVenture #VentureCapital #VC #ImpactInvesting

ViVE 2025 in Nashville did not disappoint! What a great conference of thought leaders, against the backdrop of the burgeoning Nashville healthcare ecosystem. Bolstered by innovation at Vanderbilt University and other great local initiatives, the energy and passion is alive and well in Nashville. A special treat was brunch at Cynthia Cohen's home, Founder and Chief Strategist of IMPACT 2040, with the lovely Laura Belken, Founder of Medical Mondays. Cohen is also a supporter of the Wond'ry Founder Program at Vanderbilt University—a six-month to year-long support program for newly founded ventures and their founding teams.  DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. Colucci is pictured here with DDx EIR L. Jasmine Kim (Head of Care@Home for Samsung Healthcare) and Cynthia Cohen (Founder and Chief Strategist of IMPACT 2040) #ViVEvent #HealthTechNews #HealthTechnologyNews #ImpactInvesting

DigitalDx Ventures welcomes Hoda Asmar, MD, most recently Executive Vice President and System Chief Clinical Officer for Providence Healthcare. Over her 25 years serving patients, Dr. Asmar has held senior executive roles at Providence, Adventist Health, Baptist Memorial Health Care and Presbyterian Healthcare Services. Her extensive experience at complex care delivery systems and public healthcare organizations underscores her alignment with DigitalDx’s focus on bringing value to patients and clinicians with early, affordable and accurate diagnostics. “Hoda’s understanding of the patient journey, from her roles in integrated hospital systems to public health organizations, is of great value to our portfolio companies" said DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq. “With her guidance, the solutions we invest in can truly change outcomes for patients and consumers, and impact treatment decisions for their clinicians. Her energy and passion are infectious, and we are all very excited to have her join our brain trust! “   Dr. Asmar added, "It is an honor and a privilege to join DigitalDx Ventures as an Entrepreneur in Residence and be part of its superb team of experts, clinicians, and scientists. We are collectively focused on advancing novel technologies that have a direct positive impact on outcomes and well-being for patients, consumers and clinicians." Hoda served previously as a National Baldrige examiner, chair of the board of directors for the American Association for Physician Leadership® and Board member for Civica Rx. Dr. Asmar earned her Doctor of Medicine at St. Joseph University Medical School in Beirut, Lebanon, and holds an MBA in integrative management from Michigan State University. Her clinical background is in internal medicine and infectious diseases.   Welcome Hoda Asmar!   DigitalDx Ventures is a majority women-owned impact fund focused on delivering a triple bottom line: meaningful returns, access to healthcare, and gender parity.   #venturecapitalnews #ventureinvesting #impactinvesting #biotechnews

DigitalDx Ventures is proud to announce their Spring 2025 Cohort of Venture Fellows including: Dwija Adamala, Rohan Bhardwaj, Sujin Byeon, Kyle C., Sierra Duca, PhD, RJ Grewal, Yu (Jen) Gu, Shane Harrington, Tauhid Mahmud, MD, MPH, Mauranda Men, Schuyler Melore, Christian M., Regine Nicolas, PharmD, Shivam Pandya, MD, MSKosha Rakholia, Deepa Ravikumar, MD, MBA,, Nikhil Shukla, Charan Sattiraju , Lauren Stanwicks, Anastasia Sysoeva, Darcy Tocci, Dean Wu  and Kasey Whittleston Our 220+ DigitalDx Ventures Fellows have all come from top global graduate programs and, after finishing the DDx Fellowship, go on to positions in top venture firms, consulting firms and healthcare companies. Help us grow this invaluable program and increase representation in investing to better reflect the patient population we serve by donating today. The DigtalDx Fellowship receives 10x the number of applications than we are able to accept. With this need in mind, we created this 501(c)(3) to increase our reach and multiply the impact! A few things that set the DigitalDx Fellowship apart: - 50%+ DDx Fellows are women. Our goal continues to be to create opportunities for all in advancing medical breakthroughs. -220+ DDx Fellows hail from the world’s top universities including: Princeton University, Massachusetts Institute of Technology, Johns Hopkins Medicine, McGill University, University of Oxford, Suzhou University of Science and Technology | 苏州科技大学 and work at top companies around the globe. -100% of Donations support the program this best-in-class educational program SAVVY INVESTORS KNOW: Individuals may gift anyone $18,000 per year without gift tax consequences. But, did you know that if you have an IRA that is subject to a required minimum distribution (RMD), you can gift up to $105,000 gift tax free to a nonprofit? Our team at DigitalDx can share the appropriate tax information with you. Our new team member, Erin Niehaus - CFP®, CEPA, comes from J.P. Morgan Private Bank where she helped families with philanthropic planning and she can help facilitate a discussion with you, or your financial advisor if that is helpful. For more information message: Erin Niehaus - CFP®, CEPA or Michele Colucci, Esq. DONATE at: https://lnkd.in/gBw9-7a3 #impactphilanthropy #impactgiving #impactinvesting

DigitalDx Ventures portfolio company GLX ANALYTIX was out in full force at the J.P. Morgan Morgan Healthcare Conference. The GLX team reached an important fundraise in late fall 2024 lead by DigitalDx Ventures with key additional investment from Labcorp and the Alzheimer's Drug Discovery Foundation (ADDF). GLX ANALYTIX CEO Brian DellaValle, PhD, attended JPM alongside Chief Commercial Officer Maital (Shemesh) Rasmussen and DigitalDx EIR and GLX Chief Medical and Regulatory Officer Richard Frank, MD, PhD (pictured center and below). Pictured at the JPM dinner hosted by Labcorp (top) are DellaValle with Labcorp's Director Venture Investments Sharad Mishra, MD, DigitalDx Ventures Founder + Managing Partner Michele Colucci, Esq., Labcorp's James Almas, M.D., and DigitalDx Ventures portfolio company NOWDiagnostics | NOWDx CEO Robert Weigle. In addition to DellaValle, DDx Portfolio company CEOs were omnipresent at J.P. Morgan Health Conference including: —NOWDiagnostics | NOWDx CEO Robert Weigle —Oxford Cancer Analytics CEO Peter Jianrui Liu —Biotia CEO Niamh B. O'Hara, MD Stay tuned for more exciting DigitalDx Ventures news from J.P. Morgan Healthcare week… Jerry Lanchbury Nancy Hargreaves Gisela A. Paulsen, MPharm Mackenzie Strafford Dana Sun Srinka Ghosh #HealthTech #HeathcareTechnology #JPMorgan2025 #JPMorganHealthcareConference #ImpactInvesting #healthtechnews #familyoffice #endowment #institutionalinvestor #foundations

DigitalDx Ventures Founder + Managing partner Michele Colucci, Esq. will be a featured speaker at tomorrow's HITLAB January 2025 Digital Health Symposium!  Thursday, January 30, 11 am - 2 pm ET.  The event will focus on a review of the J.P. Morgan Morgan Health Conference and feature speakers from Merck, Mount Sinai Health System, The Proficient Lab, Malo, Silicon Valley Bank (SVB), BioTrillion, The Healthcare Experience Blog, Renova Health, Kidron Capital Assets LP, and many others.     Speakers: Laurent van Lerberghe, Founder, ballas invest  Unika Alexander, CEO, The Proficient Lab Florian Le Goff, CEO of Malo Madhu Desbois, Managing and Associate Director, Malo  Mary Catherine George, Director of Clinical Research Program, Icahn School of Medicine at Mount Sinai   Savan Devani, CEO, BioTrillion   Matthew Holt, Founder, The Health Care Blog   Gracyn W. Robinson, MHL, EDAC, CEO RENOVAHEALTH Corp   Stephanie Oestreich, Managing Director, Multiple Myeloma Research Foundation - MMRF Jolene Anderson, Managing Director, VectorPoint Ventures Walter "Buzz" Stewart, CEO, Medcurio   Anula Jayasuriya, Managing Partner, Kidron Capital Assets LP Some of the topics to be addressed include:   —Insights from JP Morgan: Perspective on the Future of Digital Health and Diagnostics     —Advancing Women’s Leadership and Representation in Digital Health Research    —Unlocking Efficiency and Compliance: Embracing AI and the Future of Quality Management for Laboratories    —SVB: Healthcare Investments and Exits  Register: https://lnkd.in/ebpugNHr #healthtechinvesting #healthtech #jpmorganhealthcare2025 #hitlab2025 #healthrechnews